BeiGene
ONC
#685
Rank
C$40.18 B
Marketcap
$355.21
Share price
2.82%
Change (1 day)
79.85%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeiGene (ONC)

EPS in 2024 (TTM): -$8.58

According to BeiGene 's latest financial reports the company's current EPS (TTM) is -$8.65. .

EPS history for BeiGene from 2015 to 2024

Annual EPS

Year EPS Change
2024-$8.65
2022-$27.0428.21%
2021-$21.09-19.96%
2020-$26.3520.81%
2019-$21.8131.52%
2018-$16.58417.57%
2017-$3.20-37.16%
2016-$5.10158.95%
2015-$1.97

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.39-83.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.37-95.67%๐Ÿ‡บ๐Ÿ‡ธ USA